Advanced Search

 

Study ID Status Title Patient Level Data
205724 Not yet recruiting Randomised, Double-Blind (Sponsor Open), Placebo-Controlled, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of Danirixin Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
205744 Not yet recruiting A phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult subjects with IPSS-R high and very high risk myelodysplastic syndromes (MDS) previously treated with hypomethylating agents (HMA)
205759 Completed A single center, double-blind, randomized, placebo-controlled, parallel, single and repeat, dose-ascending study to evaluate the safety, tolerability and pharmacokinetics of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to healthy Japanese subjects
205787 Completed Assessment of Patients Treated with Albiglutide - Phase 1
205794 Completed A Study to Evaluate the Efficacy of an Experimental Occlusion Technology Dentifrice in the Relief of Dentinal Hypersensitivity
205795 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444:2010(E))
205808 Completed A double-blind, randomized, placebo controlled, dose escalating crossover study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in Japanese healthy male volunteers
205815 Not yet recruiting Horlicks Cardia+: investigating the glycaemic index and satiety effect of Horlicks Cardia+
205816 Not yet recruiting Discrete Choice Experiment in Severe Asthma
205832 Recruiting A Phase IIb, 24 week, randomized, double-blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once-daily via a dry powder inhaler, versus placebo, in participants with asthma
205846 Not yet recruiting PRJ2693: Descriptive Analysis of Neuropsychiatric Diagnoses in Patients taking Dolutegravir in the OPERA® Observational Database
205863 Not yet recruiting COPD Severity and Adherence to GOLD Guidelines in the Community Pharmacy Setting
205865 Completed Sun Protection Factor Determination: In vivo Determination of the Sun Protection Factor (SPF): ISO 24444:2010(E)
205875 Not yet recruiting A Post-Marketing Observational Study to Evaluate the Safety of Tykerb® in Chinese Patients
205907 Not yet recruiting Phenotypes of Severe Asthma among Adults in Brazil: a descriptive report of characteristics of subjects followed up in the ProAR Cohort
205911 Completed A single centre, double-blind, randomised, placebo-controlled, and single dose-ascending study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics, of single intravenous doses of GSK2315698 in healthy Japanese subjects
205913 Active not recruiting Subject Understanding of the Risks Associated with ZYBAN®, WELLBUTRIN®, WELLBUTRIN SR®, and WELLBUTRIN XL®
205915 Completed A Clinical Study to Evaluate the Ability of an Experimental Denture Adhesive to Prevent Food Particle Ingress Under Dentures
205920 Recruiting A randomized, open-label study to characterize the pharmacokinetics of inhaled oxytocin (GR121619) compared with IM oxytocin in women in the third stage of labour, and with IV oxytocin in non-pregnant, non-lactating women of childbearing potential
205930 Not yet recruiting Short term outcomes of Donation after Circulatory Death (DCD) renal transplantation in the United Kingdom
205932 Not yet recruiting New Study on the Prevalence of COPD in Spain EPI-Scan-II Study
206209 Active not recruiting An Interview Study in Adult Patients with Type 2 Diabetes Mellitus Using the Albiglutide Pen Injector
206215 Recruiting A randomized, open-label, cross-over, placebo-device study investigating critical and over all errors, training/teaching time, and preference attributes of the ELLIPTA dry powder Inhaler (DPI) as compared to HANDIHALER DPI used in combination with either DISKUS DPI or TURBUHALER DPI, in adult patients with Chronic Obstructive Pulmonary Disease (COPD)
206233 Not yet recruiting A Proof of Principle Bite Force Study Using Two New Test Adhesives and a Currently Marketed Denture Adhesive.
206239 Not yet recruiting A randomized, evaluator-blind, single-center, parallel-group clinical study designed to evaluate the local tolerance of two facial cleansers containing Benzoyl Peroxide (BPO) in comparison to a commercial control in healthy adults with mild to moderate acne vulgaris.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.